The Peel That Can Make PIH Worse—and Which Ones Don’t

If you are Fitzpatrick IV, V, or VI and you are researching chemical peels to fade hyperpigmentation, you need to know one thing immediately: glycolic acid peels are the number one cause of new post-inflammatory hyperpigmentation in darker skin. That is not a remote possibility; it is the pattern clinics see again and again when the peel choice ignores skin type. Mandelic acid and salicylic acid are consistently safer because they control depth and inflammation without the same melanocyte rebound. The rest of this article dissects exactly how those three peels compare on a depth-and-skin-type matrix, and it lays out session protocols that prevent PIH instead of gambling on it.

Mandelic Acid: The Frontline Choice for Fitzpatrick IV–VI

Mandelic acid peels are the safest starting point for anyone with melanin-rich skin who wants to treat superficial hyperpigmentation. They exfoliate while directly inhibiting tyrosinase, giving you correction and prevention in one step. Salicylic acid is a close second — and is the superior pick when acne is the engine behind the pigment. Glycolic acid can work on darker skin, but only under a regimented protocol that most patients are never given. If your goal is to fade marks without creating new ones, begin with mandelic.

Peel Risk at a Glance

Peel Type	Depth Potential	PIH Risk (Fitzpatrick IV–VI)	Anti-inflammatory Mechanism	Ideal Use Case for Dark Skin
Glycolic Acid	Superficial to medium (operator-dependent)	High	Weak — spares melanocyte at cost of dermal inflammation	Not first-line; use only with strict four-week priming and very short contact times
Mandelic Acid	Superficial only	Low	Strong — inhibits tyrosinase directly	Pigment correction, melasma, overall brightening
Salicylic Acid	Superficial (self-neutralizing)	Low	Moderate — targets acne inflammation	Active acne and post-acne marks on oily skin

Glycolic Acid Peels: Fast Penetration, High-Risk Outcome

Glycolic acid’s small molecular size is the source of its popularity for lighter skin and its danger for darker skin. It cuts through the stratum corneum quickly, often reaching the basal layer and, at common clinical concentrations, the upper dermis. In Fitzpatrick I–III, that depth yields smooth texture and pigment fading. In Fitzpatrick IV–VI, that same depth provokes melanocytes into overproduction, creating fresh PIH that takes months to fade.

The lack of a self-neutralizing mechanism compounds the problem. A glycolic peel’s endpoint depends on the person applying it: the concentration used, how well the skin was degreased, the pressure of the application, and the exact moment neutralization begins. No two sessions are identical, which means the risk of an accidental deeper peel rises with every treatment. That operator dependency makes glycolic the least reproducible acid for PIH prevention in darker skin tones.

What It Takes to Use Glycolic Safely in Darker Skin

Safely using glycolic on Fitzpatrick IV or V requires pre-treating the skin for two to four weeks with a tyrosinase inhibitor, keeping the concentration at or below 30%, and capping contact time at 2–3 minutes. Even then, the protocol demands that the provider never rely on frosting as a guide — only on a timer. Most patients who walk into a medspa for a glycolic peel are not given this protocol. That gap is precisely why glycolic leads the list of peel-induced PIH in skin of color.

Mandelic Acid Peels: Controlled Exfoliation With Built-In Pigment Safety

Mandelic acid is an alpha hydroxy acid with a molecular weight approximately double that of glycolic acid. That extra bulk slows its entry into the skin, keeping the exfoliation purely superficial. The stinging sensation that accompanies glycolic’s rapid dermal travel is muted, and with it, the inflammatory cascade that awakens melanocytes. What sets mandelic apart further is its documented inhibition of tyrosinase — the enzyme that drives melanin production. This dual mechanism (slow penetration plus direct anti-pigment action) explains why clinics that specialize in skin of colour lean on mandelic as the go-to peel for hyperpigmentation.

The Session Protocol That Works

An in-office mandelic series begins at 20–25% concentration, pH 2.5–3.0, for 3–5 minutes, with contact time increased only after the patient tolerates two sessions without any post-peel darkening. Because mandelic rarely frosts, depth is controlled by a stopwatch, not visual signs — a far more consistent method. Pre-peel priming with a tyrosinase inhibitor is still recommended, but the peel itself reduces the melanocyte activity so directly that the protocol is less brittle than glycolic’s. For home maintenance, a 5–10% mandelic serum built up over weeks can extend results without the rebound risk.

Salicylic Acid Peels: Acne-First Protection Against PIH

Salicylic acid is a beta hydroxy acid; it dissolves in oil and targets the sebaceous follicle directly. For darker-skinned individuals whose PIH originates from inflammatory acne, salicylic acid interrupts the breakout cycle at its source. It peels inside the pore, reducing microcomedones, while leaving the surrounding viable epidermis less disrupted compared to glycolic.

A critical advantage over glycolic: salicylic acid self-neutralizes as it crystallizes in the follicle. It does not continue traveling deeper. This natural brake keeps the peel epidermal, which in Fitzpatrick IV–VI translates to a dramatically lower chance of the kind of deep inflammation that fuels PIH. Salicylic also inhibits COX enzymes, providing an anti-inflammatory effect that calms the acne lesions themselves.

Where Salicylic Alone Is Not Enough

Salicylic does not directly turn off the melanocyte the way mandelic does. It reduces PIH indirectly — by extinguishing the inflammatory acne that causes it. For hyperpigmentation that is not driven by active pimples — melasma, for instance, or lingering sun-induced lentigines — salicylic’s pigment-fading power is limited compared to mandelic. The practical answer is a combined series: salicylic clears the active acne, then mandelic erases the marks left behind.

Head-to-Head on the Factors That Determine PIH

Depth Control and Reproducibility

Mandelic and salicylic peels follow reliable, limited-depth profiles because their penetration is intrinsically curbed — by molecular size for mandelic, by self-neutralization for salicylic. Glycolic’s depth, by contrast, varies according to multiple operator decisions. That inconsistency is the root of the problem for darker skin: a peel that stayed superficial once can drift medium-deep the next time, triggering PIH where there was none before.

Inflammatory Load on Melanocytes

All peels cause transient inflammation. The difference is duration and intensity. Glycolic’s fast dermal invasion can produce a burst of cytokines that wakes up melanocytes. Salicylic puts a lid on that with COX inhibition. Mandelic goes further — its anti-tyrosinase effect quiets the pigment cell while exfoliating. If the priority is PIH prevention, the choice is straightforward: minimize the inflammatory signal that turns on pigment overproduction.

Fit for Acneic Skin

When PIH is a direct result of ongoing breakouts, salicylic’s pore-clearing ability makes it the logic-based first step of a peel series. A sequence that alternates salicylic and mandelic allows the provider to attack the acne inflammation first and the stubborn pigment second, without overloading the skin in a single session.

Evidence From Clinical Practice

There are no perfect head-to-head trials stratified by Fitzpatrick type, but decades of clinical observation in dermatology journals build the same pattern: salicylic and mandelic peels are routinely performed on Fitzpatrick IV–VI with low complication rates, while glycolic’s complication rate rises as the skin tone darkens. Practices that focus solely on skin of colour rarely default to glycolic for hyperpigmentation; they start with mandelic for pigment goals and salicylic for acne goals.

Match the Peel to the Situation

Pigment Correction Without Active Acne

Use a mandelic acid series. Four to six peels at three- to four-week intervals, paired with nightly tyrosinase inhibitors, offer the safest route to visible lightening in melasma and old PIH.

Active Acne Driving PIH

Start with salicylic acid peels to bring breakouts under control. Once inflammation subsides, switch to mandelic to clear the residual marks. This sequential approach reduces the risk of peeling over angry, reactive skin.

First-Time Peel in Fitzpatrick V or VI

You should not begin with glycolic. At the darkest end of the scale, the response variability is too high. A first session should be a 20% mandelic peel at pH 3.0 for three minutes, followed by careful observation of the skin for two weeks. No hyperpigmentation? Then progress. That stepwise caution is non-negotiable.

History of Peel-Induced PIH

If your skin has already proven that it hyperpigments in response to peeling, exclude glycolic permanently. Use a mandelic-only regimen with a robust two-to-four-week priming phase and consider adding oral tranexamic acid under medical guidance. Do not rely on the peel alone to quiet reactive melanocytes.

FAQ

Can a short-contact at-home glycolic peel be safe for dark skin?

Even at home, short contact times do not eliminate the risk because the free acid penetration still depends on concentration, pH, and individual barrier state. A better approach for Fitzpatrick IV–VI is a low-percentage mandelic or salicylic serum used daily rather than a timed glycolic peel. If glycolic is used, cap it at 10% and always test a small area behind the ear first.

How fast can I expect PIH to fade with mandelic or salicylic peels?

Most patients notice lightening after two to three peels, with a more defined change by the sixth session. The timeline shortens when the underlying trigger (acne, friction) is controlled. If there is no visible change after four peels, reassess the protocol — do not simply increase peel strength.

What should I stop before a peel?

Stop all retinoids and exfoliating acids five to seven days before the session. A compromised barrier going into a peel deepens penetration and magnifies inflammation — the exact opposite of what dark skin needs. Follow the exact pretreatment timeline your provider gives you.

The PIH-Prevention Peel Protocol

The peel type is only one piece. For Fitzpatrick IV and above, the full protocol must prime, execute, and protect with precision:

• Priming (2–4 weeks): Apply a tyrosinase inhibitor each night — hydroquinone 4% (if prescribed), kojic acid, azelaic acid, or tranexamic acid. Daily broad-spectrum sunscreen with physical blockers is not optional; it is part of the peel series.
• Session day: For mandelic and salicylic peels, minimal degreasing is usually sufficient. Start the timer, control the endpoint by clock not by eye, and use cool compresses post-peel to reduce residual heat.
• First 72 hours: No actives. A bland moisturizer only. Sunscreen reapplication every two hours if outdoors. Any steroid use should only happen under explicit instruction, as it can backfire on darker skin if mismanaged.
• Between sessions: Continue tyrosinase inhibition, sunscreen, and barrier repair. If a retinoid is later introduced, separate it from the peel week by at least five days.

Glycolic can be fit into a similar protocol, but the margin for error is tighter, and the cost of a mistake is PIH that lingers for months. Mandelic and salicylic give you a protocol that is inherently more forgiving. For skin where a single misstep costs months of recovery, that forgiveness is not a minor feature — it is the whole point.

Finally, no guide replaces a dermatologist’s exam. If you have Fitzpatrick VI skin with a history of keloids or stubborn PIH, insist on a single test spot behind the ear and a two-week waiting period before any full-face peel.